Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095

RM Gulick, H Ribaudo, CM Shikuma, S Lustgarten, K Squires, WA Meyer, E Acosta, BR Schackman, CD Pilcher, RL Murphy, WE Maher, M Witt, RC Reichman, S Snyder, KL Klingman, DR Kurizkes, for the ACTG A5095 Protocol Team

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)32-43
Number of pages12
JournalN Engl J Med
Issue number350
StatePublished - 2004

Cite this